Penack, O. Et Al. 2023. ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party.. Frontiers in immunology , vol.14 , 1283034.

Penack, O., Peczynski, C., Boreland, W., Lemaitre, J., Afanasyeva, K., Kornblit, B., ... Jurado, M.(2023). ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party.. Frontiers in immunology , vol.14, 1283034.

Penack, Olaf Et Al. "ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party.," Frontiers in immunology , vol.14, 1283034, 2023

Penack, Olaf Et Al. "ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party.." Frontiers in immunology , vol.14, pp.1283034, 2023

Penack, O. Et Al. (2023) . "ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party.." Frontiers in immunology , vol.14, p.1283034.

@article{article, author={Olaf Penack Et Al. }, title={ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party.}, journal={Frontiers in immunology}, year=2023, pages={1283034} }